ELANA GEBHARD-KOENIGSTEIN: Open Payments
NPI 1316516875 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $273 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $138 |
| Botanix SB Inc | 1 | $130 |
| UCB, Inc. | 1 | $113 |
| Galderma Laboratories, L.P. | 1 | $42 |
Products named: Rhapsido, SOFDRA, Bimzelx, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
